Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does trastuzumab emtansine's patent expiry affect drug prices?Motegrity ingredients?The expiration date of the key patent for guselkumab?Dabrafenib and trametinib cost?Mobic injection patent oehringer ingelheim france?
See the DrugPatentWatch profile for aimovig
Aimovig (erenumab-aooe) is injected once a month for migraine prevention in adults. Each 140 mg subcutaneous dose uses the auto-injector or prefilled syringe, typically in the abdomen, thigh, or upper arm.[1]
Patients self-administer at home after training. Rotate injection sites to avoid irritation. The full dose is given in one injection; do not split it.[1]
Inject as soon as possible, then resume monthly schedule from that day. Do not double up. If close to the next dose (within a few days), skip and wait.[1]
Patients often ask if dosing can change based on response. Doctors may adjust to 70 mg monthly if 140 mg causes side effects like injection-site reactions, but frequency stays monthly.[1][3] [1]: Aimovig Prescribing Information (FDA) [2]: CGRP Monoclonal Antibodies Comparison (American Headache Society) [3]: Aimovig Dosing (Amgen Official Site)
Other Questions About Aimovig :